Leukemia (CLL)

« Treatment »

Clinical Trials Test State-of-the-Art Cancer Treatments

Dr. Matthew Davids Dana-Farber Cancer Institute

New treatment options allow patients with chronic lymphocytic leukemia (CLL) to live longer than they used to with the former standard of care, chlorambucil-based chemotherapy. Clinical trials are underway for a variety of options:

  • Chemo-immunotherapy
  • Monoclonal antibodies that enhance the immune system
  • Small molecule targeted therapies that take advantage of specific weaknesses in cancer cells.

Through clinical trials, doctors are able to carefully study and learn which new regimens are better at treating CLL. They’re also one of the best ways for patients to get state-of-the-art cancer treatment. You can find out if you’re eligible for a clinical trial by talking with your doctor or checking ClinicalTrials.gov.

Learn more about SurvivorNet's rigorous medical review process.

Dr. Matthew Davids is an Assistant Professor of Medicine at Harvard Medical School and the Associate Director of the Dana-Farber CLL Center. Read More

Diagnosing and Treating Advanced CLL

Experts talk to Survivornet about the significant new advances in treating patients who have recently been diagnosed with later-stage CLL.

Treatment: Oral Medications

For patients diagnosed with CLL, the go-to treatment option is usually some form of chemo-immunotherapy. But this is not an option for all patients.


Oral Medicine for Relapsed CLL: Venetoclax


Oral Medicine for CLL: Ibrutinib


Oral Medicine for Relapsed CLL

Dr. Matthew Davids
Dana-Farber Cancer Institute